Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1413-1419

  Calò, Lorenzo A ^a   Naso, Agostino ^a   Carraro, Gianni ^a   Wratten, Mary Lou ^b   Pagnin, Elisa ^a   Bertipaglia, Lara ^a   Rebeschini, Mirka ^a   Davis, Paul A ^c   Piccoli, Antonio ^a   Cascone, Carmelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Azienda Ospedaliera Padova ^*  (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Haemodiafiltration; Oxidative stress; PAI 1

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOLIC ACID; HEME OXYGENASE 1; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATE BINDING AGENT; POLYSULFONE; PROTEIN P22; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VITAMIN D;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DIALYSIS MEMBRANE; FEMALE; GENE EXPRESSION; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALE; MONONUCLEAR CELL; MORBIDITY; MORTALITY; ONLINE SYSTEM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; RNA SYNTHESIS; TREATMENT DURATION; ULTRAFILTRATION;

ADULT; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; FEMALE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENAL DIALYSIS; RISK FACTORS; RNA, MESSENGER; ULTRAFILTRATION;

EID: 34447503699     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl783     Document Type: Article

References (29)

1. Luke RG. Chronic renal failure-a vasculopathic state. N Engl J Med 1998; 339: 841-843
2. Locatelli F, Canaud B, Eckardt K et al. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280
3. Stenvinkel P, Heinburger O, Paultre F et al. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
4. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
5. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Disease 1998; 32 [Suppl 5]: S112-S119
6. De Francisco ALM, Ghezzi PM, Brendolan A et al. Hemodiafiltration with online regeneration of the ultrafiltrate. Kidney Int 2000; 58: S66-S71
7. Meloni C, Ghezzi PM, Cipriani S et al. Hemodiafiltration with post-dilution reinfusion of the regenerated ultrafiltrate: A new on-line technique. Clin Nephrol 2005; 63: 106-112
8. Ghezzi PM, Gervasio R, Tessore V et al. Hemodiafiltration without replacement fluid: An experimental study. ASAIO J 1992; 38: 61-65
9. Calò LA, Pagnin E, Davis PA et al. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: Relevance for angiotensin II signalling. Nephrol Dial Transplant 2003; 18: 1518-1525
10. Calò LA, Davis PA, Giacon B et al. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol 2002; 40: 625-631
11. Calo LA, Naso A, Pagnin E et al. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis-a molecular biological approach. Clin Nephrol 2004; 62: 355-361
12. Calo LA, Bertipaglia L, Pagnin E et al. Effect of doxazosin on oxidative stress related proteins in essential hypertensive patients. Clin Exp Hypertens 2006; 28: 181-188
13. Pagnin E, Davis PA, Sartori M et al. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: Relationship to angiotensin II signaling. J Hypertens 2004; 22: 1963-1969
14. Calò LA, Pagnin E, Davis PA et al. Antioxidant effect of L-carnitine and its short chain esters. Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 2006; 107: 54-60
15. Galli F, Ronco C. Oxidant stress in hemodialysis. Nephron 2000; 84: 1-5
16. Tetta C, Biasioli S, Schiavon R et al. An overview of haemodialysis and oxidant stress. Blood Purif 1999; 17: 118-126
17. Panichi V, Manca-Rizza G, Paoletti S et al. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: A cross-over randomized multicentre trial. Nephrol Dial Transplant 2006; 21: 756-762
18. Morena M, Cristol JP, Bosc JY et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 422-427
19. Babior BM. NADPH oxidase: An update. Blood 1999; 93: 1464-1476
20. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. TCM 1998; 8: 59-64
21. Dhalla NS, Temsha RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-673
22. Dimova EY, Samoylenko A, Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal 2004; 6: 777-791
23. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3: 1879-1883
24. Dichtl W, Stiko A, Eriksson P et al. Oxidized LDL and Lysophosphatidylcholine Stimulate Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 1999; 19: 3025-3032
25. Agirbasli M. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 2005; 59: 102-106
26. Meisinger C, Baumert J, Khuseyinova N et al. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005; 112: 651-657
27. Maines MD. The heme oxygenase system:a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554
28. Stocker R, Yamamoto Y, McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046
29. Nath KA, Vercellotti GM, Grande JP et al. Heme protein-induced chronic renal inflammation: Suppressive effect of induced Heme oxygenase-1. Kidney Int 2001; 59: 106-117